Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Calculators
Do not call
En
Track Curis Lifesciences Ltd’s IPO performance through its subscription period, issue details, and investor participation across categories.
The Curis Lifesciences IPO opened on November 7, 2025, drawing investor attention to India’s growing pharmaceutical innovation sector. The company’s book-built issue, worth ₹27.52 crore, offers shares priced between ₹120 and ₹128.
On its opening day, the Curis Lifesciences Ltd IPO recorded steady investor participation, driven primarily by interest from institutional buyers. The issue, which opened on November 7, 2025, has drawn attention from investors tracking India’s growing pharmaceutical and healthcare innovation sector. The IPO remains open for subscription until November 11, 2025.
By the end of Day 1, the issue was subscribed 1.54x overall, driven primarily by strong QIB demand.
| Investor Category | Subscription (Times) |
|---|---|
Qualified Institutional Buyers (QIB) |
4.85x |
Retail Individual Investors (RII) |
0.27x |
Non-Institutional Investors (NII) |
0.48x |
Total |
1.54x |
Institutional investors were the main contributors, signaling market confidence in Curis’ long-term pipeline strategy.
By the end of Day 2, the Curis Lifesciences Ltd IPO has achieved an overall subscription of 4.09x.
| Investor Category | Subscription (Times) |
|---|---|
Qualified Institutional Buyers (QIB) |
-16.89x |
Retail Individual Investors (RII) |
2.74x |
Non-Institutional Investors (NII) |
2.22x |
Total |
4.09x |
The Non-Institutional Investor (NII) and Retail Individual Investor (RII) categories have shown strong participation.
By the final day of bidding, Curis Lifesciences Ltd. witnessed overwhelming investor participation across all categories. The issue was subscribed 24.60x overall, driven by exceptionally strong demand from institutional and non-institutional investors.
| Investor Category | Subscription (Times) |
|---|---|
Qualified Institutional Buyers (QIB) |
35.63x |
Non-Institutional Investors (NIIs) |
31.39x |
Retail Individual Investors (RIIs) |
14.35x |
Total |
24.60x |
The QIB category led the momentum with 35.63x subscription, followed closely by NIIs at 31.39x, reflecting significant institutional confidence in the company’s growth potential in the life sciences sector. Retail participation remained robust, contributing to an impressive overall performance.
The Curis Lifesciences Ltd IPO price band is fixed between ₹120 and ₹128 per share, with a face value of ₹10 per equity share. Investors can bid for a minimum of 1,000 shares (1 lot) and in multiples of 1,000 shares thereafter.
At the upper band of ₹128, one lot amounts to an investment of ₹1,28,000, offering investors an affordable entry into India’s rapidly expanding pharmaceutical manufacturing and R&D ecosystem.
The well-defined lot structure ensures inclusive participation — from retail investors seeking exposure to the healthcare sector’s resilience to institutional players betting on the company’s research-driven growth potential.
| Investor Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
Retail (Min/Max) |
1 |
1,000 |
₹1,28,000 |
S-HNI (Min) |
2 |
2,000 |
₹2,56,000 |
S-HNI (Max) |
8 |
8,000 |
₹10,24,000 |
B-HNI (Min) |
9 |
9,000 |
₹11,52,000 |
This investment structure provides flexibility to investors of all scales and highlights Curis Lifesciences’ intent to attract both long-term value seekers and institutional stakeholders.
For ongoing updates on subscription progress and allotment details, visit the Curis Lifesciences IPO on Bajaj Markets.
Following is the whole IPO schedule, highlighting important dates for investors — from bidding to listing:
| Event | Date | Details |
|---|---|---|
IPO Open Date |
November 7, 2025 |
Bidding begins |
IPO Close Date |
November 11, 2025 |
Final bidding day |
Basis of Allotment |
November 12, 2025 |
Allocation finalisation |
Refund Date |
November 13, 2025 |
Refunds processed |
Credit of Shares |
November 13, 2025 |
Shares credited to Demat |
Listing Date |
November 14, 2025 |
Expected SME listing date |
Note: These dates represent procedural milestones based on publicly available data and are intended for informational purposes only.
Investors can apply for the Curis Lifesciences Ltd IPO through ASBA (via Net Banking) or UPI (through broker platforms). Both options ensure a safe, SEBI-compliant, and paperless application experience.
Follow these steps to apply via your bank’s ASBA service:
Log in to your internet banking account.
Go to the ‘Investments’ or ‘IPO Application’ section.
Choose ‘Curis Lifesciences Ltd IPO’ from the list.
Enter your bid quantity (number of lots) and bid price.
Confirm and submit the application.
The application amount will be blocked in your account until the allotment process.
Upon allotment, the corresponding amount will be debited, and shares will be credited to your Demat account.
You can also apply through your broker’s platform or investment app using UPI:
Log in to your Demat account or trading account on your broker platform.
Navigate to the IPO section and select ‘Curis Lifesciences Ltd IPO’.
Enter your application details, such as number of lots and price.
Provide your UPI ID linked to your bank account.
Approve the mandate request in your preferred UPI app (such as BHIM, Google Pay, or PhonePe).
The funds will be blocked until allotment and debited only if shares are allotted.
Upon allotment, the shares will be credited to your Demat account.
The information provided above is based on publicly available data from reliable financial news and market sources. Investors are advised to verify figures and consult financial experts before making investment decisions. Market conditions and subscription numbers are subject to change during the IPO window.
Sources
LiveMint — IPO News and Updates, https://www.livemint.com/market/ipo
Economic Times — IPO News: Latest IPO News, Upcoming IPO, https://economictimes.indiatimes.com/markets/ipo
Financial Express — IPO News, https://www.financialexpress.com/market/ipo-news/
NDTV Profit — IPOs, https://www.ndtvprofit.com/ipos
Business Today — IPO Corner: Latest IPO News & Analysis, https://www.businesstoday.in/markets/ipo-corner
.jpeg)
66100
Unlock the world of credit! From picking the perfect card to savvy loan management, navigate wisely.
43326
Money Management and Financial Planning covers personal finance basics, setting goals, budgeting...
19348
Explore the investment cosmos! From beginner's guides to sharp-witted strategies, explore India's treasure trove of options.
34594
Navigate the tax maze with ease! Uncover Income Tax 101, demystify jargon with Terms for Beginners, and choose between Old or New Regimes.
3261
Discover essential insights on various types of insurance in India.
4388
Welcome to Tech in Finance, where we explore the exciting intersection of technology and finance...
Personal Loan, Business Loan, Collateral
Credit Score, Report & Analysis
Fixed Deposit, Mutual Fund, NPS, Demat A/C, SGB
General Insurance, Life Insurance, Term Insurance
Stocks, IPOs
Smart Phone, Speaker, EarPhone
Academy 
.jpeg "image not found")
